Thorac Cardiovasc Surg 2015; 63(04): 313-318
DOI: 10.1055/s-0034-1389085
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Mid-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass Grafting

Diana Reser
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
,
Mathias van Hemelrijck
2   University of Zurich, Zurich, Switzerland
,
Jovana Pavicevic
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
,
Herman Tolboom
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
,
Tomas Holubec
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
,
Volkmar Falk
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
,
Stephan Jacobs
1   Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland
› Author Affiliations
Further Information

Publication History

30 April 2014

02 July 2014

Publication Date:
10 September 2014 (online)

Abstract

Background Minimally invasive direct coronary artery bypass grafting (MIDCAB) has gained wide acceptance for the treatment of single vessel disease of the left anterior descending artery (LAD). Here, we present our single center experience of 152 consecutive patients.

Materials and Methods All patients underwent MIDCAB through a left anterior minithoracotomy between January 1, 2009, and December 31, 2012. Preoperative, intraoperative, postoperative, and follow-up data including major adverse cardiac and cerebrovascular events (MACCE) and need for re-intervention were collected.

Results Mean age was 64.4 ± 11 years, median additive EuroSCORE 3 (0–11), 84% were male. All except one patient were successfully operated without cardiopulmonary bypass. Seven patients with unexpected severely calcified LADs were converted to sternotomy (4.6%); 91.3% were extubated in the operating room or on the day of surgery. Median stay at the intensive care unit and in hospital were 1 (0–97) and 7 (1–49) days, respectively. Thirty-day mortality was 1.9%. There was no stroke. Five patients (3.2%) had to be re-explored for bleeding and 95% received no transfusion. Median follow-up was 24 months (0–97) and complete in 93.3% with overall survival of 92.4 ± 0.2% and MACCE-free survival of 96.1 ± 1.7%. Two patients had a re-intervention of the LAD.

Conclusion MIDCAB is a safe procedure with low postoperative morbidity, mortality, and favorable mid-term MACCE-free survival in selected patients that should be discussed in a heart team setting to evaluate the “ideal” individual treatment option.

 
  • References

  • 1 Kolessov VI. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967; 54 (4) 535-544
  • 2 Holzhey DM, Cornely JP, Rastan AJ, Davierwala P, Mohr FW. Review of a 13-year single-center experience with minimally invasive direct coronary artery bypass as the primary surgical treatment of coronary artery disease. Heart Surg Forum 2012; 15 (2) E61-E68
  • 3 Jacobs S, Holzhey D, Falk V, Garbade J, Walther T, Mohr FW. High-risk patients with multivessel disease—is there a role for incomplete myocardial revascularization via minimally invasive direct coronary artery bypass grafting?. Heart Surg Forum 2007; 10 (6) E459-E462
  • 4 Holzhey DM, Jacobs S, Mochalski M , et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg 2008; 86 (6) 1856-1860
  • 5 Booth J, Clayton T, Pepper J , et al; SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008; 118 (4) 381-388
  • 6 Al-Ruzzeh S, Mazrani W, Wray J , et al. The clinical outcome and quality of life following minimally invasive direct coronary artery bypass surgery. J Card Surg 2004; 19 (1) 12-16
  • 7 Vicol C, Nollert G, Mair H , et al. Midterm results of beating heart surgery in 1-vessel disease: minimally invasive direct coronary artery bypass versus off-pump coronary artery bypass with full sternotomy. Heart Surg Forum 2003; 6 (5) 341-344
  • 8 Rogers CA, Pike K, Angelini GD , et al. An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: the Sternotomy Versus Thoracotomy (STET) trial. J Thorac Cardiovasc Surg 2013; 146 (2) 306-316 , e1–e9
  • 9 Aziz O, Rao C, Panesar SS , et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007; 334 (7594) 617
  • 10 Benedetto U, Raja SG, Soliman RF , et al; Harefield Cardiac Outcomes Research Group. Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: A 10-year follow-up, single-center, propensity score analysis. J Thorac Cardiovasc Surg 2014; ; E-pub ahead of print
  • 11 Holzhey DM, Jacobs S, Mochalski M , et al. Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann Thorac Surg 2007; 83 (1) 108-114
  • 12 O'Keefe Jr JH, Kreamer TR, Jones PG , et al. Isolated left anterior descending coronary artery disease: percutaneous transluminal coronary angioplasty versus stenting versus left internal mammary artery bypass grafting. Circulation 1999; 100 (19, Suppl): II114-II118
  • 13 Goy JJ, Kaufmann U, Hurni M , et al; SIMA Investigators. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial. J Am Coll Cardiol 2008; 52 (10) 815-817
  • 14 Mohr FW, Morice MC, Kappetein AP , et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381 (9867) 629-638
  • 15 Takagi H, Watanabe T, Mizuno Y, Kawai N, Umemoto T ; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A meta-analysis of large randomized trials for mid-term major cardio- and cerebrovascular events following off-pump versus on-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2014; 18 (4) 522-524
  • 16 Kettering K. Minimally invasive direct coronary artery bypass grafting: a meta-analysis. J Cardiovasc Surg (Torino) 2008; 49 (6) 793-800
  • 17 Biglioli P, Antona C, Alamanni F , et al. Minimally invasive direct coronary artery bypass grafting: midterm results and quality of life. Ann Thorac Surg 2000; 70 (2) 456-460
  • 18 Raffa GM, Malvindi PG, Ornaghi D , et al. Minimally invasive direct coronary artery bypass in the era of percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 2013;
  • 19 Lapierre H, Chan V, Sohmer B, Mesana TG, Ruel M. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study. Eur J Cardiothorac Surg 2011; 40 (4) 804-810
  • 20 Kapoor JR, Gienger AL, Ardehali R , et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv 2008; 1 (5) 483-491
  • 21 Thiele H, Neumann-Schniedewind P, Jacobs S , et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol 2009; 53 (25) 2324-2331
  • 22 Yan TD, Padang R, Poh C , et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg 2011; 141 (5) 1134-1144
  • 23 Kolh P, Wijns W, Danchin N , et al; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010; 38 (Suppl): S1-S52
  • 24 Gummert JF, Funkat AK, Beckmann A , et al. Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2011; 59 (5) 259-267
  • 25 Birla R, Patel P, Aresu G, Asimakopoulos G. Minimally invasive direct coronary artery bypass versus off-pump coronary surgery through sternotomy. Ann R Coll Surg Engl 2013; 95 (7) 481-485
  • 26 Calafiore AM, Di Giammarco G, Teodori G , et al. Midterm results after minimally invasive coronary surgery (LAST operation). J Thorac Cardiovasc Surg 1998; 115 (4) 763-771
  • 27 Koch CG, Li L, Duncan AI , et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81 (5) 1650-1657